Company · MDT
Medtronic plc.
Name as listed on its exchange; filed with the SEC as Medtronic plc.
Nasdaq's symbol directory lists MDT on the New York Stock Exchange as “Medtronic plc. Ordinary Shares”.
In the 12 months to Nov 8, 2026: insiders sold on 5 occasions ($6.5M); 4 planned-sale notices; 6 congressional trade disclosures; 3 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Martha Geoffrey, Chairman and CEO sold $4.8M
- Marinaro Michael, EVP, Pres MedSurg and Americas sold $1.0M
- KIIL HARRY SKIP, EVP & President Cardiovascular sold $476K
- Walter Matthew R., SVP, Chief HR Officer sold $258K
Every trade (5)
- SELLMartha Geoffrey, Chairman and CEO sold $4.8M
- SELLMarinaro Michael, EVP, Pres MedSurg and Americas sold $1.0M
- SELLKIIL HARRY SKIP, EVP & President Cardiovascular sold $139K
- SELLWalter Matthew R., SVP, Chief HR Officer sold $258K
- SELLKIIL HARRY SKIP, EVP & President Cardiovascular sold $337K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Martha Geoffrey $4.8M
- Marinaro Michael $1.0M
- KIIL HARRY SKIP $139K
- Walter Matthew R. $258K
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Kevin Hern (R-OK01): Sale $15,001 - $50,000
- Richard Dean Dr McCormick (R-GA06): Sale $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Sale $1,001 - $15,000
- Alan Armstrong (R-OK): Purchase $1,001 - $15,000
- Kevin Hern (R-OK01): Sale $15,001 - $50,000
- Julie Johnson (D-TX32): Sale $1,001 - $15,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Departure or appointment of directors or officers; Submission of matters to a vote of security holders; Regulation FD disclosure Oct 19, 2026
- Other events Sep 17, 2026
- Results of operations and financial condition Sep 1, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.